Westbury Diagnostics, Inc.

A major pharmaceutical company was developing a new therapeutic agent. As with most new drugs, tens of thousands of compounds had been synthesized and screened. Most of these compounds were found to have little activity for their intended use. The company did not however want to dispose of them, and so they were stored. An R&D director at the company believed that while these compounds might not be active for their intended use, that they might have antimicrobial activity. Westbury was contacted and developed a rapid protocol to quickly and effectively screen compounds for antimicrobial activity against a wide range of microorganisms. Several of the hundreds of compounds tested by us did in fact have antimicrobial activity and this was reported back to the company.